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 1 
ABSTRACT 2 
Elaborate antioxidant pathways have evolved to minimize the threat of excessive reactive oxygen 3 
species (ROS) and to regulate ROS as signaling entities.  ROS are chemically and functionally 4 
similar to reactive sulfide species (RSS) and both ROS and RSS have been shown to be 5 
metabolized by the antioxidant enzymes, superoxide dismutase and catalase.  Here we use 6 
fluorophores to examine the effects of a variety of inhibitors of antioxidant pathways on 7 
metabolism of two important RSS, hydrogen sulfide (H2S with AzMC) and polysulfides (H2Sn, 8 
where n=2-7, with SSP4) in HEK293 cells.  Cells were exposed to inhibitors for up to 5 days in 9 
normoxia (21% O2) and hypoxia (5% O2), conditions also known to affect ROS production.  10 
Decreasing intracellular glutathione (GSH) with L-buthionine-sulfoximine (BSO) or diethyl 11 
maleate (DEM) decreased H2S production for 5 days but did not affect H2Sn.  The glutathione 12 
reductase inhibitor, auranofin, initially decreased H2S and H2Sn but after two days H2Sn 13 
increased over controls.  Inhibition of peroxiredoxins with conoidin A decreased H2S and 14 
increased H2Sn, whereas the glutathione peroxidase inhibitor, tiopronin, increased H2S. 15 
Aminoadipic acid, an inhibitor of cystine uptake did not affect either H2S or H2Sn.  In buffer, the 16 
glutathione reductase and thioredoxin reductase inhibitor, 2-AAPA, the glutathione peroxidase 17 
mimetic, ebselen, and tiopronin variously reacted directly with AzMC and SSP4, reacted with 18 
H2S and H2S2, or optically interfered with AzMC or SSP4 fluorescence.  Collectively these 19 
results show that antioxidant inhibitors, generally known for their ability to increase cellular 20 
ROS, have various effects on cellular RSS.  These findings suggest that the inhibitors may affect 21 
cellular sulfur metabolism pathways that are not related to ROS production and in some 22 
instances they may directly affect RSS or the methods used to measure them.  They also 23 
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illustrate the importance of carefully evaluating RSS metabolism when biologically or 24 
pharmacologically attempting to manipulate ROS. 25 
 26 
Key Words: reactive sulfide species; reactive oxygen species; antioxidants 27 
28 
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1. Introduction 29 
 It is becoming more apparent that redox environments in various intracellular 30 
compartments are physiologically regulated to optimize electron transfer and prevent electrons 31 
from ‘wandering off’ and disrupting cellular processes.  Although, numerous oxidants can arise 32 
from a variety of intracellular processes, or be ingested in the diet, the production of reactive 33 
oxygen species (ROS), namely peroxide (H2O2) has received the most attention as it has been 34 
implicated a variety of aspects of oxidative stresses from signaling (eustress) to mobilization of 35 
antioxidant responses (oxidative stress), and if this fails the resulting oxidative distress can lead 36 
to catastrophic consequences [1-19]. 37 
 Regulation of, and protection from ROS is attributed to a hierarchy of antioxidant 38 
mechanisms that include ROS buffers and a compliment of enzymes that facilitate transfer of 39 
electrons from NADPH to the oxidant or oxidized cellular constituent, the latter often a thiol on a 40 
regulatory or structural protein.  Thiols are also the redox currency of the major intracellular 41 
redox buffer, glutathione, and the cadre of redox enzymes, peroxiredoxins, thioredoxins, 42 
thioredoxin reductases, glutaredoxins and glutathione reductases employed to maintain this 43 
balance.  Chemically targeting these antioxidant systems has been used to examine their relative 44 
regulatory roles as well as to disrupt redox balance as a therapeutic tool [20-31]. 45 
 We have noted striking similarities between ROS and reactive sulfide species (RSS) and 46 
have proposed that in some instances the former could be mistaken for the latter in cellular 47 
functions [32].  Sequential one-electron reductions of O2 produces superoxide(O2•-), hydrogen 48 
peroxide (H2O2), hydroxyl radical (HO•) and H2O, whereas one-electron oxidation of hydrogen 49 
sulfide (H2S) progressively forms a thiyl radical (HS•), hydrogen persulfide (H2S2) and persulfide 50 
“supersulfide” radical (HS2•-) before terminating in elemental sulfur (S2), the latter usually 51 
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cyclizing to S8.  The primary target of both peroxide and persulfide is the above-mentioned 52 
cysteine on regulatory proteins and the effects of peroxidation or persulfidation on the function 53 
of a number of proteins has been shown to be identical [17,33-40].  Furthermore, many methods 54 
routinely employed to measure ROS also detect RSS, at times with greater sensitivity [41]. 55 
 Although the “Redox Code” posits that concept of antioxidant protection was believed to 56 
be “richly elaborated in an oxygen-dependent life, where activation/deactivation cycles involving 57 
O2 and H2O2 contribute to spatiotemporal organization for differentiation, development, and 58 
adaptation to the environment” [42], an argument can be made for antioxidants in the regulation 59 
of RSS.  Essentially all antioxidant buffers and above-mentioned enzymes appeared within the 60 
first several hundred million years after life’s beginnings 3.8 billion years ago [43-51].  At this 61 
time the oceans were anoxic and sulfidic [52,53] and it would take over a billion years for the 62 
“great oxidation event” to slightly nudge atmospheric O2.  It wasn’t until 600 million years ago, 63 
after nearly seven-eighths of evolution had passed, before the oceans became oxic.  As the 64 
origins of antioxidant mechanisms likely coincided with the advent of anoxygenic 65 
photosynthesis, a process that has been proposed to oxidize H2S to polysulfides and reduce CO2 66 
to methane and other organic compounds [32] it would seem that control of sulfur-based redox 67 
reactions would have been a priority, perhaps not only for redox balance but for general 68 
metabolism.  We proposed that many of these pathways remain in extant animals and perform 69 
similar functions. 70 
 We recently examined the possibility that sulfur was metabolized by two antioxidant 71 
enzymes, superoxide dismutase (SOD) and catalase, and indeed this appeared to be the case.  72 
Both Cu/Zn and Mn SOD oxygen-dependently oxidized H2S to polysulfides, initially forming 73 
persulfide (H2S2) and subsequently longer chain polysulfides (H2Sn where n=3-5) but did not 74 
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metabolize polysulfides [54].  Bovine catalase also oxidized H2S to polysulfides in the presence 75 
of either O2 or H2O2, whereas in hypoxia it produced H2S from either thioredoxin or the sulfur-76 
reductant dithiothreitol (DTT), a process that required NADPH [55].  Furthermore, the partial 77 
pressure of oxygen at which the catalase switched from an oxidase to a reductase (P50) which is 78 
20 mmHg, is striking similar to the P50 of the oxyhemoglobin saturation curve (26 mmHg) 79 
suggesting that catalase, which is abundant in red blood cells, oxidizes H2S during normoxia, 80 
whereas as blood Po2 falls, not only is O2 unloaded from hemoglobin, but vasodilator H2S is 81 
produced to augment O2 delivery. 82 
 In the present study we further examine sulfur (RSS) metabolism in HEK293 cells by 83 
blocking endogenous antioxidant pathways while monitoring endogenous H2S and polysulfides 84 
with specific fluorophores (AzMC and SSP4, respectively).  We show that these antioxidant 85 
inhibitors have profound effects on cellular RSS that are not consistent with concomitant effects 86 
on ROS and propose that some of the effects of manipulating cellular antioxidant pathways may 87 
be mediated by RSS. 88 
  89 
2. Materials and methods 90 
2.1.  Chemicals 91 
 SSP4 (3', 6'-Di(O-thiosalicyl)fluorescein) was purchased from Dojindo molecular 92 
Technologies Inc. (Rockville, MD).  All other chemicals were purchased either from Sigma-93 
Aldrich (St. Louis, MO) or ThermoFisher Scientific (Grand Island, NY).  Please note that we use 94 
H2S to denote the total sulfide added (sum of H2S + HS-) usually derived from Na2S.  Also, 95 
while S2- is often thought as part of the H2S + HS- equilibrium, it does not exist under 96 
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physiological conditions [56].  Phosphate buffer (PBS; in mM): 137 NaCl, 2.7, KCl, 8 Na2HPO4, 97 
2 NaH2PO4. pH was adjusted with 10 mM HCl or NaOH to 7.4. 98 
 99 
2.2. Effects of inhibitors on sulfur metabolism in cells 100 
 Human embryonic kidney (HEK293) cells were cultured and maintained at 37o C in a 5% 101 
CO2 humidified incubator with 21% O2 supplemented with DMEM (low glucose) containing 102 
10% FBS and 1% Pen/Strep.  In a typical experiment they were transferred from a T-25 tissue 103 
culture flask to two 96 well plates with gas-permeable bottoms (Coy Laboratory Products, Inc. 104 
grass Lake, MI) and grown to 80–95% confluency.  The cells were then treated with either an 105 
H2S sensitive fluorophore 7-azido-3-methylcoumarin (AzMC, 25 µM) or a polysulfide sensitive 106 
fluorophore 3',6'-Di(O-thiosalicyl)fluorescein (SSP4, 10 µM).  Excitation/emission wavelengths 107 
for AzMC and SSP4 were 365/450 and 482/515, respectively per manufacture’s 108 
recommendations.  Fluorescence was measured on a SpectraMax M5e plate reader (Molecular 109 
Devices, Sunnyvale, CA) according to the manufacturer’s recommendations   Inhibitors of H2S 110 
biosynthesis or sulfur doors were typically added after an initial baseline reading and one plate 111 
was returned to the 21% O2 incubator (normoxia) and the other placed in a model 856-HYPO 112 
hypoxia chamber (Plas Labs, Inc. Lansing, MI) and incubated in 5% O2/5% CO2 balance N2 113 
(hypoxia) at 37o C for 3-5 days.  Previous studies have shown that this prolonged hypoxia 114 
produces a sustained increase in cellular H2S and these studies were designed to determine if any 115 
inhibitors specifically affected the hypoxic response. 116 
 117 
2.3.  Effects of inhibitors on fluorescence and sulfur metabolism in buffer 118 
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 The inhibitors used in this study could give an erroneous impression of an effect on 119 
cellular sulfur metabolism if they directly interacted with AzMc and SSP4 or H2S and 120 
polysulfides.  Three groups of experiments were performed to examine these possibilities.  In the 121 
first group, the inhibitors were added directly to the fluorophores to determine if they specifically 122 
activated the fluorophores.  In the second group, the inhibitors were added to concomitantly with 123 
200 µM H2S and either AzMC or SSP4.  A decrease in AzMC fluorescence would suggest that 124 
either the inhibitors catalyzed H2S consumption or there was a direct interference of the reaction 125 
between H2S and AzMC.  An increase in SSP4 fluorescence in these experiments would suggest 126 
that the inhibitors catalyzed the oxidation of H2S to polysulfides.  In the third group of 127 
experiments 10 µM of H2S was incubated with AzMC, or 30 µM of K2Sn was incubated with 128 
SSP4 for 120 min to determine if the inhibitors interfered with fluorescence of AzMC or SSP4 129 
after thethe fluorophores were activated by the sulfur moiety.  In these experiments the H2S and 130 
K2Sn concentrations were chosen to produce approximately the same fluoresence as that 131 
observed in the cell experiments and 120 min allowed for the fluorophore-sulfur reaction to be 132 
completed. 133 
 The compounds of interest were aliquoted into black 96 well plates in a darkened room 134 
and fluorescence was measured on a SpectraMax M5e plate reader (Molecular Devices, 135 
Sunnyvale, CA).  Fluorescence was typically measured every 10 min over 90 min.   The inhibitor 136 
concentrations were selected to bracket the concentrations used in the cell experiments.  All 137 
experiments were performed at room temperature (20o C). 138 
 139 
2.4. Cell viability 140 
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 Cell viability was determined using the PrestoBlue fluorophore per manufacturer’s 141 
directions.  PrestoBlue was either added at the end of an experiment or to PBS and fluorescence 142 
measured 1 and 2 h later at 535/615 nm (Ex/Em). 143 
 144 
2.5. Verification of AzMC specificity 145 
 An anonymous reviewer expressed some concern regarding the specificity of AzMC as a 146 
H2S fluorophore.  To examine this we first examined the effects of GSH, -3MP, H2O2 and the 147 
NO donor sodium nitroprusside on AzMC fluorescence in PBS.  We then incubated HEK293 148 
cells with inhibitors of H2S biosynthesis, propargylglycine (PPG; 10 mM) and 1 mM 149 
aminooxyacetate (AOA; 1 mM).  PPG is a relatively selective inhibitor of cystathionine γ lyase 150 
and AOA is an inhibitor of both CSE and cystathionine β-synthase (CBS). 151 
 152 
2.6.  Calculations 153 
 Results are expressed as mean +SE. Statistical analysis was determined by one-way 154 
ANOVA with Holm-Sidak for multiple comparisons. Significance was assumed at p≤0.05. 155 
 156 
3.  Results 157 
3.1.  Effects of BSO and DEM on intracellular H2S and polysulfides in HEK293 cells  158 
 Both L-buthionine-sulfoximine (BSO) and diethyl maleate (DEM) decreased intracellular 159 
GSH and increased ROS in primary cortical cultures containing both neurons and astrocytes 160 
[57].  The concentration-dependent effects of BSO and DEM on H2S (AzMC fluorescence) in 161 
both normoxic (21% O2) and hypoxic (5% O2) HEK293 cells are shown in Fig. 1.  Although the 162 
BSO-hypoxia control cells were lost due to medium leaking from the wells, there was a clear 163 
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decrease in AzMC fluorescence between 0.3 µM BSO and 1 µM BSO supporting the conclusion 164 
that both BSO and DEM concentration-dependently decreased AzMC fluorescence in normoxic 165 
and hypoxic cells. The effects of BSO and DEM on polysulfides (SSP4 fluorescence) in 166 
HEK293 cells in hypoxia (5% O2) are also shown in Fig. 1. Neither BSO nor DEM greatly 167 
affected SSP4 fluorescence, the rapid initial increase in SSP4 fluorescence in all samples likely 168 
reflects a large pre-existing polysulfide pool in these cells and may have masked specific effects 169 
of the inhibitors. 170 
 In order to determine if the effects of BSO or DEM were on cellular H2S and polysulfides 171 
we then explored potential interactions of the inhibitors with fluorophores in buffer (Figs. S1, 172 
S2, respectively).  Neither BSO nor DEM directly reacted with otherwise unactivated 173 
fluorophore, nor did they affect the reaction of the fluorophores with H2S or with H2S-activated 174 
AzMC or K2Sn-activated SSP4.  These results suggest that both BSO and DEM directly inhibit 175 
intracellular H2S production but do not affect endogenous polysulfides or polysulfide production. 176 
 177 
3.2. Effects of cystine, BSO and DEM on H2S and polysulfide metabolism in HEK293 cells  178 
 Although both BSO and DEM decrease intracellular GSH and increase ROS, DEM 179 
increases cystine uptake while BSO decreases it [57].  In order to determine if cystine affected 180 
the actions of these inhibitors on cellular sulfur metabolism we incubated HEK293 cells with 181 
combinations of 200 µM cystine, 10 µM BSO and 100 µM DEM (Fig. 2).  Cystine decreased 182 
intracellular H2S, but it was less than half as effective as either BSO or DEM and the effects of 183 
either BSO or DEM were not affected by addition of cystine.  SSP4 fluorescence was unaffected 184 
by cysteine, BSO, DEM, or by combinations of cystine and BSO or cystine and DEM.  These 185 
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results suggest that the effects of BSO and DEM on intracellular H2S metabolism are 186 
independent of cystine uptake and not related to their effects on intracellular ROS. 187 
 Figure 2 also shows that cystine alone decreases AzMC but does not affect SSP4 188 
fluorescence in HEK293 cells. Cystine also had direct effects on the fluorophores in buffer but 189 
these were opposite of those produced in cells (Fig. S3).  Cystine slightly increased fluorescence 190 
of both AzMC and SSP4 alone and it concentration-dependently increased SSP4 fluorescence 191 
when added in conjunction with H2S.  Cystine produced approximately a 20% increase in AzMC 192 
fluorescence when added 120 min after AzMC but this was not dependent on cysteine 193 
concentration; cystine did not affect fluorescence of SSP4 pre-incubated with K2Sn (Fig. S4).  194 
The effects of cystine on cellular polysulfides remain to be clarified. 195 
 196 
3.3.  Effects of auranofin on intracellular H2S and polysulfides in HEK293 cells  197 
 Auranofin is an irreversible inhibitor of glutathione reductase (GSHR) and increases 198 
intracellular ROS [27,28,58,59].   The concentration-dependent effects of auranofin on sulfur 199 
metabolism are shown in Fig. 3.  Auranofin concentration-dependently decreased the time 200 
dependent rate of both AzMC and SSP4 fluorescence increase in normoxic and hypoxic cells. 201 
 The effects of auranofin in buffer are shown in Fig. S5. In buffer, auranofin did not 202 
directly react with otherwise unactivated fluorophore nor did it affect the reaction of AzMC with 203 
H2S.  However, auranofin decreased SSP4 fluorescence in the presence of H2S but not in the 204 
presence of H2S-activated AzMC or K2Sn-activated SSP4.  The concentration-dependent 205 
decrease in SSP4 fluorescence produced by auranofin in HEK293 cells was evident at the initial 206 
4 hr sample and the rate of increase in SSP4 fluorescence thereafter was not appreciably different 207 
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between the un-treated and auranofin-treated samples suggesting that the anurafin effects were 208 
indirect. 209 
 210 
3.4. Effects of combined auranofin and BSO or DEM treatment on H2S and polysulfide 211 
metabolism in HEK293 cells 212 
 The combined effects of 10 µM BSO, 100 µM DEM and either 3 or 10 µM auranofin are 213 
shown in Fig. 4.  In these experiments the inhibitors were added to the cells on the first day, 214 
whereas the fluorophores were added to different groups of cells on day 1, 2, 3 and 4.  This 215 
combination of inhibitors nearly completely inhibited H2S production when applied on the first 216 
day and this level of inhibition remained for the duration of the experiment.  Polysulfide 217 
production was not appreciably affected with 3 µM auranofin when the SSP4 was given on the 218 
first day but was decreased with 10 µM auranofin.  However, the degree of inhibition of SSP4 219 
fluorescence appeared to progressively wane when the SSP4 was given after day one and by 220 
days 2-3 SSP4 fluorescence was greater in auranofin-treated cells.  These effects on AzMC 221 
fluorescence are consistent with the individual effects of the inhibitors whereas there appears to 222 
be cellular over-compensation in polysulfide metabolism.  This compensation required auranofin 223 
as it was not observed with either BSO or DEM when these experiments were repeated in the 224 
absence of auranofin (not shown). 225 
 226 
3.5. Effects of conoidin A on H2S and polysulfide metabolism in HEK293 cells 227 
 Conoidin A covalently binds and inhibits peroxiredoxins [60]. The effects of conoidin A 228 
on sulfur metabolism in HEK293 cells are shown in Fig. 5.  Conoidin A concentration-229 
dependently decreased AzMC fluorescence and greatly increased SSP4 fluorescence in both 230 
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normoxic and hypoxic HEK293 cells.  With 100 µM conoidin A AzMC fluorescence was 231 
severely depressed, even at t=0 h suggesting that conoidin A directly interfered with AzMC, and 232 
indeed this appeared to be the case.  In buffer conoidin A concentration-dependently decreased 233 
AzMC fluorescence by itself, in conjunction with H2S, and after H2S had reacted with AzMC for 234 
120 min (Fig. S6).  In all instances there was an apparent threshold of 3 µM (5% inhibition) and 235 
at 100 µM more than half of the AzMC fluorescence was inhibited.  These results suggest that 236 
with conoidin A concentrations above 3 µM the effects on cellular AzMC fluorescence are 237 
indirect and probably due to optical quenching.  However, the inhibitory effects of 1 µM 238 
conoidin A on AzMC fluorescence in cells could be due to direct inhibition of cellular H2S as 239 
this concentration did not affect AzMC fluorescence in buffer.  Conoidin A also decreased SSP4 240 
fluorescence in buffer (Fig. S6), clearly the opposite of its effects in cells, indicating that 241 
conoidin A directly increases intracellular polysulfides. 242 
 243 
3.6. Effects of tiopronin on H2S and polysulfide metabolism in HEK293 cells 244 
  The effects of tiopronin, an inhibitor of cystine uptake, on AzMC and SSP4 fluorescence 245 
in HEK293are shown in Fig. 6.  Tiopronin concentration-dependently increased AzMC 246 
fluorescence in normoxic HEK293 cells and this was further increased in hypoxic cells.  For 247 
example, at 21 h 1 mM tiopronin increased AzMC fluorescence 4.9-fold in hypoxic cells 248 
compared to a 3.4-fold increase in normoxic cells.  After 21 h AzMC fluorescence progressively 249 
declined in hypoxic cells but continued to rise, albeit slowly in normoxic cells.  In buffer 250 
tiopronin increased AzMC fluorescence by approximately 40% (Fig. S7) but this was only 1500 251 
to 2000 fluorescence units compared to the increase of over 10,000 fluorescence observed in 252 
cells.  When added in conjunction with H2S, tiopronin decreased AzMC fluorescence (Fig. S7) 253 
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by 40%, but when added 120 min after AzMC and H2S tiopronin did not inhibit fluorescence 254 
between 500 µM and 2 mM and inhibited it by only 25% at 4 mM.  These results indicate that 255 
topronin substantially increases intracellular H2S and that this increase is even greater in hypoxic 256 
cells. 257 
 SSP4 fluorescence was decreased by tiopronin in normoxia and hypoxia with the most 258 
notable response in hypoxic cells treated with 1 mM tiopronin.  As shown in Fig. S7, tiopronin 259 
partially inhibited SSP4 fluorescence when added directly to SSP4, when added in conjunction 260 
with H2S and when added 120 min after SSP4 was incubated with K2Sn.  These results indicate 261 
that tiopronin likely has little effect on intracellular polysulfides. 262 
 263 
3.7. Effects of ebselen on H2S and polysulfide metabolism in HEK293 cells 264 
 Effects of the glutathione peroxidase and peroxiredoxin mimetic on AzMC and SSP4 265 
fluorescence are shown in Fig. 7.  Ebselen concentration-dependently decreased intracellular 266 
AzMC fluorescence in normoxic and hypoxic HEK293 cells but had minimal effects on SSP4 267 
fluorescence with the exception of a delayed increase in fluorescence.  The effects of ebselen on 268 
AzMC fluoresence in cells are likely indirect.  As shown in Fig. S8, while ebselen did not 269 
directly react with buffer, it decreased AzMC fluorescence by 70% when added concurrently 270 
with H2S but only slightly (<20%) decreased fluorescence when added 120 min after H2S.  271 
Ebselen also profoundly increased SSP4 fluorescence (600%) when added concurrently with H2S 272 
and SSP4 but did not affect SSP4 fluorescence when added directly to SSP4 or 120 min after 273 
K2Sn was added to SSP4.  These results suggest that ebselen directly catalyzes polysulfide 274 
formation from H2S.  Additional studies are required to clarify ebselen’s effects in cells. 275 
 276 
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3.8. Effects of 2-AAPA on H2S and polysulfide metabolism in HEK293 cells 277 
 The irreversible inhibitor of glutathione reductase (GSHR) and thioredoxin reductase 278 
(TrxR), 2-AAPA, concentration-dependently decreased AzMC fluorescence in normoxic and 279 
hypoxic HEK293 cells (Fig. 8).  2-AAPA also increased cellular SSP4 fluorescence, which at 20 280 
µM was 3-4 times that of untreated cells.  This increase was noted immediately after application 281 
of 2-AAPA and it declined by ~15% within the first 4 h. 282 
 In buffer, 2-AAPA appeared to directly react with AzMC, increasing fluorescence by 283 
approximately 40% at all concentrations (10, 20 and 40 µM; Fig. S9).  But when 2-AAPA was 284 
added to AzMC in the presence of 100 µM H2S it appeared to slightly decrease fluorescence but 285 
this was due to variability in the initial concentrations of fluorophore (t=0 min) and not to 2-286 
AAPA; the ratio of fluorescence between H2S and 10, 20 or 40 µM 2-AAPA at t=0 min (0.74, 287 
1.10 and 0.65, respectively) was not appreciably different from their ratios at 10 min (0.75, 0.99, 288 
0.65) or 90 min (0.86, 0.97, 0.70).  A minimal (<10%) decrease in fluorescence was also 289 
observed when 2-AAPA was added 120 min after H2S had reacted with AzMC.  Collectively, 290 
these results suggest that 2-AAPA may directly decrease intracellular H2S, however this needs to 291 
be confirmed. 292 
 The effects of 2-AAPA on intracellular SSP4 fluorescence, appears to be due to direct 293 
interactions between 2-AAPA and SSP4 (Fig. S9).  Direct addition of 2-AAPA to SSP4 294 
produced a concentration- and time-dependent increase in fluorescence that for 10, 20 and 40 µM 295 
2-AAPA was 37, 55 and 77 times greater, respectively than SSP4 alone at 90 min.  2-AAPA also 296 
increased fluorescence when SSP4 was added to H2S, albeit to a lesser degree.  However, 2-297 
AAPA did not affect fluorescence of SSP4 after the latter had reacted with polysulfides, 298 
presumably because at this time there was little un-reacted SSP4 left.  Although these results do 299 
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not provide any direct information on intracellular polysulfide metabolism, they clearly illustrate 300 
the need to carefully evaluate potential interfering reactions with test compounds and 301 
fluorophores. 302 
 303 
3.9. Effects of aminoadipic acid on H2S and polysulfide metabolism in HEK293 cells 304 
 Aminoadipic acid is a competitive substrate for the system Xc- transporter and decreases 305 
cellular uptake of cystine.  Aminoadipic acid did not affect either AzMC or SSP4 fluorescence in 306 
HEK293 cells (Fig. 9).  In buffer aminoadipic acid did not directly react with AzMC or SSP4, 307 
but decreased AzMC (15%) and SSP4 (35%) fluorescence when incubated concurrently with 308 
H2S or after 120 min of SSP4 reaction with polysulfides (15%; Fig. S10).  As there was no 309 
cystine in the medium in these experiments, these results suggest that aminoadipic acid has little 310 
effect on intracellular sulfur metabolism in HEK293 cells. 311 
  312 
3.10. Short-term effects of select inhibitors 313 
 A number of the inhibitors used in this study had apparent effects on H2S and polysulfide 314 
metabolism within the first 4 hours.  These effects were then examined on a shorter time scale to 315 
get a better appreciation of their impact on H2S and polysulfide metabolism. 316 
 As shown in Fig. 10, BSO did not appreciably affect AzMC fluorescence, whereas an 317 
inhibitory effect of 300 µM DEM was evident within the first hour.  This is as expected because 318 
BSO inhibits GSH synthesis but does not immediately react with GSH, whereas DEM directly 319 
reacts with GSH.  By the first hr, 1 mM tiopronin increased H2S.  The effects of 300 µM and 100 320 
µM tiopronin became evident by hrs 2 and 3, respectively.  The inhibitory effects of conoidin A 321 
on AzMC fluorescence were evident even at the initial (t=0 hr) sample suggesting that these 322 
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were due to a direct inhibitory effect on the fluorphore which is supported by the buffer studies 323 
(Fig. S6). 324 
 Conoidin A produced concentration-dependent increases in SSP4 fluorescence within the 325 
first 15 min (Fig. 11).  Although much of the inhibitory effect of 3 µM auranofin appeared to be 326 
indirect, as shown by the decrease in fluorescence at t=0 hr, auranofin also appeared to delay the 327 
subsequent increase in fluorescence suggesting a possible inhibitory effect in the cells as well 328 
(Fig. 11). 329 
 330 
3.11. PrestoBlue; effects of inhibitors and thiols 331 
 The effects of antioxidant pathway inhibitors on cell viability was first examined by 332 
incubating HEK293 cells in 5% O2 with either BSO and DEM (10 and 100 µM, respectively), 333 
conoidin A (10 µM) or tiopronin (1 mM) for 46 h in the presence of either AzMC or SSP4 then 334 
adding PrestoBlue and measuring PrestoBlue fluorescence one and two hours later (47 and 48h).   335 
AzMC and SSP4 fluorescence was monitored at 0, 2, 20, 24, 28 and 44 h to confirm the effects 336 
of the inhibitors on H2S and polysulfide production. The effects of the inhibitors on AzMC and 337 
SSP4 fluorescence at 0 and 44 h are shown in Fig. 12 A,C, respectively and PrestoBlue 338 
fluorescence in cells is shown in Fig. 12 B,D, respectively and Fig. 12 E shows PrestoBlue 339 
fluorescence in PBS. Consistent with previous observations, at 44 h BSO plus DEM and 340 
conoidin A decreased AzMC fluorescence, whereas tiopronin increased it.  SSP4 fluorescence 341 
was slightly increased by tiopronin, greatly increased (~5 times) by conoidin A and decreased by 342 
tiopronin. 343 
 With the PrestoBlue method cell viability is determined by the reduction of the non-344 
fluorescent resazurin to fluorescent resorufin, which purportedly occurs in the reducing 345 
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environment of live cells but not in the more oxidizing environment of dead ones [61].  In 346 
AzMC-treated cells, Prestoblue fluorescence was greater in the control cells than it was in PBS 347 
after 1 h incubation and fluorescence increased further in the cells but not in PBS at hour two.  348 
This indicates that the HEK293 cells are still viable after 48 h in 5% O2.  In AzMC-treated cells, 349 
both BSO plus DEM and tiopronin produced a further increase in PrestoBlue fluorescence 350 
compared to control cells, whereas fluorescence was decreased by conoidin A after 2 h 351 
incubation.  Prestoblue fluorescence in all SSP4-treated cells was not significantly different from 352 
that in PBS. 353 
 AzMC, SSP4, H2S (as Na2S) or mixed polysulfides (as K2Sn, n=1-7) were then incubated 354 
with PrestoBlue in PBS in order to determine they directly affected PrestoBlue fluorescence.  As 355 
shown in Fig. S11, neither AzMC nor SSP4 directly affected PrestoBlue fluorescence, whereas 356 
Na2S doubled PrestoBlue fluorescence by 30 min and K2Sn immediately increased fluorescence 357 
by over 13 fold.  Incubation of Na2S with AzMC or of K2Sn with SSP4 for one hour prior to 358 
addition of Prestoblue eliminated most of the effect of these sulfides on Prestoblue fluorescence.  359 
As shown in Fig. S12A,B, the effect of K2Sn on PrestoBlue fluorescence was clearly 360 
concentration-dependent and both DTT and 3MP increased PrestoBlue fluorescence, whereas 361 
neither cysteine nor cystine appeared to react with PrestoBlue. 362 
 363 
3.12. Verification of AzMC specificity 364 
 The effects of GSH, 3-MP, H2O2 and the NO donor sodium nitroprusside on AzMC 365 
fluorescence in PBS are shown in Fig. S13A.  None of these compounds, even at the highest 366 
concentrations, had any appreciable effect on AzMC fluorescence compared to H2S. 367 
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AzMC fluorescence increased in HEK293 cells over 48 h and this was slightly, but 368 
significantly (p<0.05) inhibited by AOA+PPG at 48h.  Hypoxia greatly increased AzMC 369 
fluorescence and this was inhibited by AOA+PPG at both 24 and 48 h (Fig. S13B).  These 370 
results indicate that AzMC fluorescence reflects cellular H2S production because inhibitors of 371 
H2S biosynthesis produced the expected decrease in fluorescence. 372 
  373 
4. DISCUSSION 374 
 Peroxiredoxin, thioredoxin and glutathione/glutaredoxin antioxidant systems reduce H2O2 375 
to H2O by transfering electrons from NADPH via two or more cysteine relay proteins and GSH, 376 
the so-called “thiol switches” [21,62-67].  These processes depend on close apposition of the 377 
relay molecules and interference with any component will affect their efficacy.  This property 378 
explains the general observation that the variety of inhibitors used in the present study increase 379 
intracellular H2O2 and this has been employed in some therapeutic applications, albeit with 380 
variable success [22-28,31,59,68-71]. 381 
 Given the chemical and biological similarities between H2O2/H2O and H2S2/H2S, and the 382 
role of cysteine and protein thiols in sulfur metabolism, it seems logical to assume that these 383 
antioxidant inhibitors would also uniformly decrease H2S and increase H2S2 if they acted via the 384 
canonical ROS antioxidant pathways.  Failing to observe this (summarized in Table 1), we 385 
conclude that these antioxidant systems perform completely different functions with respect to 386 
cellular sulfur metabolism and that these may be independent of the ROS-regulating relay 387 
switches or they may function in conjunction with heretofore unidentified substrates and enzyme 388 
pathways.  Our previous observations that catalase, in a NADPH-dependent process, forms H2S 389 
from either thioredoxin, or DTT [55] provides a precedent for this hypothesis. 390 
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 The ‘conventional’ and ‘unconventional’ pathways of H2S and polysulfide metabolism 391 
have been summarized in a recent review 72] and provide a convenient starting point for 392 
examining the observed effects of ROS antioxidant inhibitors on cellular sulfur metabolism in 393 
the present study. H2S production from L-cysteine, and to a lesser extent L-homocysteine, via the 394 
actions of cystathionine γ lyase (CSE), cystathionine β synthase (CBS), and the tandem activities 395 
of cysteine amino acid transferase (CAT) and 3-mercaptopyruvate sulfur transferase (3-MST) 396 
have been well established as has been H2S production from D-cysteine by D-amino acid oxidase 397 
and 3-MST.  H2S can also be produced from polysulfides, although this has been less well 398 
characterized in cells.  Polysulfides are often thought to arise from oxidation of H2S catalyzed by 399 
enzymes such as sulfide quinone oxidoreductase and 3-MST, transition metals, heme proteins 400 
and uncatalyzed reactions with nitric oxide (NO).  CSE and CBS have also been reported to form 401 
cysteine per- and polysulfides (CysSSnH; typically n=1-4) from cystine [73] although this may 402 
not be physiologically relevant [74].  Recently, Akaike et al. [74] provided compelling evidence 403 
that cysteine is persulfidated and polysulfidated by another, sulfur-donating cysteine in a reaction 404 
that is catalyzed by cysteinyl tRNA synthase (CARS).  These per- and polysulfide cysteine are 405 
co-translationally incorporated into proteins a reaction also catalyzed by CARS.  Two CARS, 406 
cytoplasmic (CARS1) and mitochondrial (CARS2) are found in eukaryotes with most 407 
persulfidation resulting from CARS2, the latter providing the majority of both of mitochondrial 408 
as well as cytoplasmic polysulfides.  CysSSnH may account for as much as 70-80% of the 409 
protein cysteine and there appears to be a vast interconnected network between polysulfdated 410 
proteins and small molecular weight thiols for sulfur signaling, storage and transfer [75,76].  411 
This large polysulfide network is also apparent in our observation of the rapid and substantial 412 
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increase in SSP4 fluorescence in the present experiments.  Several aspects of the actions of the 413 
inhibitors used in the present study deserve special attention in this regard. 414 
 A number of studies suggest that Trx and 3-MST appear to occupy a unique position at 415 
the junction between H2S/polysulfide metabolism and antioxidant pathways. As we have shown 416 
catalase catalyzed the production of H2S in the presence of NADPH [55].  It has also been shown 417 
that Trx releases H2S from 3MP-persulfidated 3-MST [77] and both H2S and polysulfides are 418 
released from a 3-MST tri-sulfide that is formed when thiosulfate reacts with 3-MST [78].  419 
Reduced Trx also cleaves the intersubunit Cys-Cys bond of an oxidized, inactivated 3-MST 420 
dimer thereby reactivating the enzyme [79].  In the brain, 3-MST produces a variety of cysteine 421 
and glutathione per- and polysulfides as well as H2S and H2Sn [80,81] and the persulfide 422 
concentration has been reported to be nearly equal to the concentration of H2S [82,83].  Germane 423 
to the present study, it has recently been shown that exogenous H2S prevents H2O2-induced cell 424 
death in cells treated with auranofin, which was presumed to inhibit Trx.  These studies also 425 
showed that H2S didn’t affect Trx ptotein levels but favored dissociation of Trx from the 426 
endogenous thioredoxin inhibitor, TXNIP (thioredoxin-interacting protein; [84].  See also 427 
reviews; [78,85]. 428 
 429 
4.1. BSO and DEM 430 
 Glutathione (GSH) is at the center of cellular redox balance, both as a the most prevalent 431 
intracellular ROS buffer and as an intermediary in the GSH/glutaredoxin antioxidant system 432 
[62].  Both BSO and DEM decrease intracellular GSH over 24 hrs in primary cortical cultures 433 
containing both neurons and astrocytes, however, the mechanisms are different [57].  BSO 434 
inhibits γ-glutamylcysteine synthase, the rate-limiting enzyme in GSH synthesis, which increases 435 
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intracellular cysteine, decreases cystine uptake and increases oxidative stress [57,70].  DEM 436 
directly conjugates to GSH which lowers intracellular cysteine and stimulates cystine uptake.  437 
DEM may [68] or may not [57] increase oxidative stress. 438 
 Despite the opposite effects of BSO and DEM on intracellular cysteine, both inhibitors 439 
decreased intracellular H2S without affecting polysulfides.  Although we used different cells than 440 
those examined by Albano et al. [57], our results suggests that of BSO and DEM have the same 441 
effects in HEK293 cells then perhaps as much as half of the H2S production in HEK293 cells is 442 
derived from a sulfur moiety other than cysteine.  This is supported by our recent observations 443 
that inhibiting CSE, CBS and 3-MST with drugs or by siRNA only decreases cellular H2S 444 
production by half (Olson et al., in review).  Evidence that the inhibitory effects of BSO and 445 
DEM on H2S are mediated via GSH is further supported by the relatively rapid inhibitory effect 446 
of DEM compared to BSO (Fig. 10) which we interpret as the immediate lowering of GSH due 447 
to DEM binding compared to BSO which inhibits GSH synthesis but does not directly remove 448 
affect GSH. 449 
 It is possible that H2S is derived directly from GSH or that GSH mediates some 450 
transsulfuration process with another polysulfide than then releases H2S. The identity of this per- 451 
or polysulfide is unknown.  However, it is doubtful that this is cystine.  Cystine does not appear 452 
to be a source of H2S in HEK293 cells [74] and we showed that it actually decreased intracellular 453 
H2S (Fig. 2).  Furthermore, the cystine effect cannot be indirect as it slightly increased both 454 
AzMC and SSP4 fluorescence in buffer (Fig S3).  The inability of exogenous cystine to affect 455 
BSO- and DEM-induced reduction in intracellular H2S, despite the fact that DEM increases 456 
cystine uptake via induction of system Xc- transporter [57,86] and BSO decreases it [57] further 457 
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supports the hypothesis that these compounds do not act through an indirect effect on cellular 458 
cysteine or cystine. 459 
 460 
4.2. Auranofin 461 
 Auranofin is an irreversible inhibitor of the seleno-antioxidant enzymes, glutathione 462 
reductase and thioredoxin reductase [27,58,59].  Auranofin, like BSO and DEM, increases ROS 463 
in cells and in our studies it decreased AzMC fluorescence, as did BSO and DEM (Fig. 3).  464 
Unlike BSO or DEM, auranofin also decreased SSP4 fluorescence (Fig. 3).  This latter effect 465 
could be attributable to a direct effect on the interaction of SSP4 with polysulfides as auranofin 466 
inhibited the reaction of SSP4 with K2Sn to the same extent (Fig. S5), although if SSP4 was 467 
administered to HEK293 cells several days after auranofin there was an increase in polysulfides 468 
suggesting a rebound from an initial inhibition of polysulfide production (Fig. 4).  Both AzMC 469 
and SSP4 are irreversible RSS fluorophores and provide a history of the amount of RSS 470 
produced not the current concentration.  By adding SSP4 on consecutive days after auranofin, 471 
BSO and DEM, as we did in Fig. 4, we were able to follow polysulfide production at different 472 
time points and the delayed increase in SSP4 fluorescence in treated cells suggests this rebound 473 
effect. 474 
 475 
4.3. Conoidin A 476 
 Conoidin A concentration-dependently decreased cellular H2S and increased polysulfides 477 
(Figs. 5, 10, 11) with the effect on the latter appearing fairly rapid, i.e., within the initial few 478 
hours and becoming even more pronounced over the ensuing two days.  The effects on 479 
polysulfides were unlike that produced by any other inhibitor suggesting that conoidin A has 480 
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specific effects on polysulfide metabolism.  As conoidin A is a covalent inhibitor of 481 
peroxiredoxin [60], our results implicate peroxiredoxins in polysulfide metabolism. 482 
 Peroxiredoxins are ubiquitously distributed in eukaryotes and well known for their ability 483 
to scavenge as much as 90% of intracellular H2O2.  Recent evidence suggests that they also play 484 
key roles in H2O2 signaling [64-66].  Like the other antioxidants examined in our study, 485 
peroxiredoxins employ cysteine redox switches.  As eloquently discussed by Stöcker et al. [66], 486 
the conundrum of H2O2 signaling is the fact that peroxisomes are far more prevalent in cells and 487 
have a much greater affinity for H2O2 than do the putative target thiols of regulatory proteins.  So 488 
the question becomes, how can H2O2 selectively react with the appropriate target?  Stöcker et al. 489 
[66] offer two possibilities, in the first, two-step relay, the H2O2-oxidized peroxidase oxidizes an 490 
intermediary oxidoreductase which then acts as a relay between the initial peroxidase and target 491 
protein.  In the second one-step mechanism the peroxidase forms a complex with the target 492 
protein and the oxidizing equivalents are transferred directly from the peroxidase to the target.  493 
Spatial constraints in the site(s) of oxidant production and effector receptivity can convey 494 
additional specificity.  Our results suggest a third signaling possibility, H2S, which is produced in 495 
response to a stressor, e.g., hypoxia [87], is oxidized by peroxiredoxins to a polysulfide which 496 
then persulfidates the cysteine of the regulatory protein.  This mechanism may resolve another 497 
conundrum, that being the identity of the oxygen sensor by supporting RSS via H2S [87] in favor 498 
of ROS [88]. 499 
 500 
4.4. Tiopronin 501 
 Glutathione peroxidases (GPx) are a family of selenocysteine-containing enzymes that 502 
catalytically degrade H2O2 consuming two GSH and in the process generating oxidized 503 
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glutathione (GSSG) and H2O.  Tiopronin is a reversible glutathione peroxidase inhibitor believed 504 
to exert biological activity in part by ROS scavenging mediated by its thiol group [25,89,90].  505 
Given that GPx consumes GSH it seems likely that tiopronin would increase GSH if GPx was 506 
actively metabolizing H2O2.  We observed that tiopronin produced a profound increase in 507 
intracellular H2S (Figs. 6, 10) that could not be attributed to a direct effect of tiopronin on 508 
interactions between AzMC, H2S and tiopronin, all of which tended to decrease AzMC 509 
fluorescence (Fig. S7).  These results support, albeit in a correlational context, the role of GSH in 510 
H2S production; tiporonin increases GSH and H2S while BSE and DEM decrease GSH and H2S 511 
supporting the concept of H2S production that is independent of intracellular cysteine. 512 
 513 
4.5. Avoiding artifacts; interference, interactions and other considerations 514 
 Most analytical methodologies are developed with consideration for specificity regarding 515 
analytes with chemical similarities, whereas other potential artifacts are less commonly 516 
identified.  These pitfalls have been pointed out with respect to ROS [91,92].  We also 517 
considered the possibility that fluorophores (and an amperometric H2O2 electrode) that were 518 
designed to measure ROS also detected RSS and showed that this indeed was the case.  Two of 519 
these, the redox-sensitive green fluorescent protein, roGFP and the H2O2 electrode, were actually 520 
far more sensitive to RSS than they were to ROS [41].  Fortunately for the present study, neither 521 
AzMC nor SSP4 appear to react with H2O2, the NO donor diethylamine NONOate or the free 522 
radical dipotassium nitrosodisulfonate (Fremy’s salt) and AzMC does not react with polysulfides 523 
and SSP4 does not react with H2S [93].  However, Bibli et al. also reported that AzMC was 524 
approximately 4.6, 3.6 and 2.5 times more sensitive to Cys, 3-MP and GSH, respectively than it 525 
was to H2S [93].  We did not observe this dramatic of an effect of Cys, which only increased 526 
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AzMC fluorescence by less than 15% (Fig. S3A).  Nor did we observe any appreciable effect of 527 
GSH, 3-MP, H2O2 or the NO-donor sodium nitroprusside on AzMC fluorescence (Fig. S13A) 528 
suggesting that these compounds do not interfere with H2S-mediated AzMC fluorescence.  529 
Furthermore, we also observed that inhibitors of H2S biosynthesis also inhibited AzMC 530 
fluorescence in HEK293 cells indicating that AzMC is an effective probe of cellular H2S 531 
production.  While these do not encompass all possible ROS or RSS, we can at least rule out a 532 
few of the more probable interfering molecules. 533 
 In the present study we looked for three other potential problems, reactions between the 534 
fluorophores and inhibitors (left panels in Figs. S1-S10), reactions between the inhibitors and 535 
RSS (middle panels in Figs. S1-S10) and optical quenching or other interference of the RSS-536 
activated fluorophore by the inhibitors (right panels in Figs. S1-S10).  These experiments 537 
showed potential problems with a number of inhibitors that could affect interpretation of their 538 
effects on RSS in cells.  Conoidin A appeared to interfere with both AzMC and SSP4 539 
fluorescence (Fig. S6) which obviated definitive conclusions of its effect on cellular H2S 540 
metabolism but not on polysulfide production as it increased SSP4 fluorescence in cells.  541 
Tiopronin also interfered with AzMC and SSP4 fluorescence in buffer (Fig. S7) but produced the 542 
opposite response in cellular AzMC fluorescence suggesting it too had a direct effect on cellular 543 
H2S production.  2-AAPA appeared to directly react with SSP4 (Fig. S9), while ebselen 544 
appeared to catalyze H2S oxidation to polysulfides which resulted in a decrease in AzMC 545 
fluorescence and an increase in SSP4 fluorescence (Fig. S8).  It was not possible to ascertain if 546 
either 2-AAPA or ebselen affected cellular RSS.  Nor can we conclude that H2S and polysulfides 547 
are the only RSS affected by these inhibitors.  Sulfenyl cysteine persulfide (Cys-SSOH) has 548 
recently been identified [94] that could escape undetected if not reactive with SSP4 as could 549 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
other polysulfoxides [95].  These all need to be resolved as the RSS methodologies are 550 
developed. 551 
 We have previously shown that a number of metal-centered porphyrins and the 552 
porphyrin-containing antioxidant enzyme, catalase, optically interfere with fluorescein-type 553 
fluorophores [96] so the effects of the inhibitors in the present study was not entirely 554 
unanticipated.  We have also shown that a number of the methods used to measure ROS cannot 555 
distinguish between ROS and RSS [41].  Most notably, we found that the redox-sensitive green 556 
fluorescent protein, roGFP, arguably the gold standard ROS probe [97], is two hundred times 557 
more sensitive to RSS than it is to ROS.  The redox sensitivity of roGFP is derived from two 558 
cysteines inserted into the protein that form an easily reduced disulfide bridge that when oxidized 559 
changes the fluorescence absorption spectrum [98].  This clearly explains the responsivity of 560 
roGFP to RSS.  roGFPs have also been fused with redox catalysts.  roGFP fused to 561 
peroxiredoxins or Orp1 is reported to provide real time H2O2 probes [99-101], and when fused 562 
with glutaredoxin it is reported to be a very specific probe for the 2GSH/GSSG redox couple 563 
[101].  The sensitivity of all of these modified roGFP probes to RSS will need to be examined 564 
before it can be concluded that they are specific for ROS-related events or if they also report 565 
RSS activities. 566 
 567 
4.6. Is PrestoBlue a polysulfide probe? 568 
 Reduction of resazurin (PrestoBlue) by the reducing environment in viable cells produces 569 
the fluorescent resorufin and is the basis for this assay [61] and our application in the present 570 
stidy (Fig. 12).  Using this method we showed that HEK293 cells remained viable for up to 48 h 571 
in 5% O2.  We also showed that cells treated with BSO plus DEM, conoidin A or tiopronin also 572 
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reduced Prestoblue suggesting that these inhibitors also did not affect viability.  However, 573 
conoidin A halved and tiopronin doubled PrestoBlue fluorescence in AzMC-treated cells, 574 
whereas an increase in PrestoBlue fluorescence was not observed in cells treated with SSP4.  575 
These findings suggest that either, 1) AzMC and/or SSP4 directly affect PrestoBlue fluorescence, 576 
2) SSP4 kills HEK293 cells, or 3) H2S and/or polysulfides reduce resazurin to resorufin.  Our 577 
evidence of these reactions in buffer (Fig. S11) suggests the latter.  First, neither AzMC nor 578 
SSP4 directly affected PrestoBlue fluorescence. Second, if SSP4 killed the cells then we would 579 
not expect to see SSP4 fluorescence increase in cells over time nor that this would be 580 
differentially sensitive to inhibitors whose effects were shown to be cell-dependent.  In the 581 
absence of cells, we clearly showed that both H2S and polysulfides reduce PrestoBlue and that 582 
polysulfides are far more efficacious in so doing.  Figure S12 clearly shows that this is not a 583 
general effect of thiols as while DTT and 3MP also reduced PrestoBlue, cysteine and cystine did 584 
not.  This suggests that endogenous H2S, polysulfides or select thiols also are responsible for 585 
reducing PrestoBlue in cells.  The greater efficacy of polysulfides compared to H2S is likely due 586 
to the fact that they are better reductants than H2S [76].  So why does SSP4 prevent any 587 
PrestoBlue reduction in cells?  We propose that this is due to SSP4 binding to endogenous 588 
polysulfides as they are formed before the polysulfides can reduce the Prestoblue.  Evidence for 589 
this is shown by incubating SSP4 with polysulfides for one hour prior to addition of PrestoBlue 590 
which essentially completely inhibits the effect of polysulfides. 591 
 Our results also suggested that the mechanism of PrestoBlue reduction in live cells is due, 592 
at least in part, to endogenous polysulfides or other thiols.  They also suggest the possibility that 593 
the supposed oxidation of dead cells which inhibits Prestoblue reduction is not due to increased 594 
ROS such as H2O2 but due to decreased production of persulfide or other thiol.  If both conoidin 595 
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A and tiopronin were to increase ROS, as generally assumed (see introduction), then both should 596 
have the same effect on PrestoBlue fluorescence, i.e., to decrease it.  However, we not only show 597 
that these inhibitors have the opposite effects on PrestoBlue fluoresence in cells, but that these 598 
effects are identical to their effects on cellular H2S. Clearly, additional work is necessary to 599 
identify the actual thiols that are responsible for PrestoBlue fluorescence. 600 
4.7. Summary 601 
 The present experiments suggest that a variety of compounds commonly used to affect 602 
cellular redox balance by inhibiting antioxidant pathways also affect cellular H2S and 603 
polysulfides.  These experiments also indicate that the effects of these inhibitors on sulfur 604 
metabolism cannot be explained by disruption of the canonical ROS antioxidant pathways and 605 
subsequent secondary effects of these ROS on sulfur metabolism.  Rather they suggest that these 606 
inhibitors directly affect cellular sulfur metabolism, potentially via established pathways and/or 607 
other mechanisms that remain to be identified. 608 
 609 
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 614 
Table 1.  Summary of effects of ROS inhibitors on H2S and polysulfides in HEK293 cells. 615 
 616 
Inhibitor Target H2S Polysulfides Buffer# 
    AzMC SSP4 
BSO γ-GCS Dec (C-D) NC NC NC 
DEM binds GSH Dec (C-D) NC NC NC 
Auranofin GSHR Dec (C-D) Dec (C-D) NC Dec (40) 
Conoidin A Prx Dec (C-D)* Inc (C-D) Dec (60) Dec (40) 
Tiopronin GPx Inc (C-D) NC* Dec (35) Dec (80) 
2-AAPA GSHR, TrxR Dec (C-D)* Inc* Dec (30) Inc (230) 
ADA  CSSC uptake NC NC NC Dec (30) 
Ebselen H2O2 scavenger Dec (C-D)* Inc* Dec (70) Inc (570) 
 617 
Abbreviations; ADA, aminoadipic acid; AzMC, H2S fluorophore; BSO, L-buthionine-618 
sulfoximine; C-D, concentration dependent; CSSC, cystine; Dec, decrease; DEM, diethyl 619 
maleate; γ-GCS, γ-glutamylcysteine synthase; GSH, glutathione; Gpx, glutathione peroxidase 620 
GSHR, glutathione reductase; Grx, glutaredoxin; Inc, increase; NC, no change; Prx, 621 
perodiredoxin; Trx, thioredoxin; TrxR, thioredoxin reductase; *, effects may be mediated by 622 
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direct interaction with fluorophore or sulfides. #, only pronounced and consistent effects on 623 
AzMC or SSP4 are considered; (maximum percent change) . 624 
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 897 
FIGURE CAPTIONS 898 
Figure 1.  Concentration-dependent inhibitory effects of BSO and DEM on AzMC fluorescence 899 
in HEK293 cells in either normoxia (21% O2) or hypoxia (5% O2) and effects of 10 µM BSO or 900 
100 µM DEM on SSP4 fluorescence in HEK293 cells (right panels).  Mean +SE, n=8 wells all 901 
experiments. 902 
 903 
Figure 2.  Effects of 10 µM BSO and 100 µM DEM with or without 200 µM cystine on AzMC 904 
and SSP4 fluorescence in normoxic HEK293 cells.  Cystine alone decreased AzMC fluorescence 905 
but did not significantly affect the greater inhibitory effects of either BSO or DEM on AzMC 906 
fluorescence.  SSP4 fluorscence was unaffected by cystine, BSO, DEM, alone or in combination.  907 
Mean +SE, n=8 wells all experiments. 908 
 909 
Figure 3.  Auranofin concentration-dependently inhibits AzMC and SSP4 fluorescence in 910 
HEK293 cells in both normoxia (21% O2) or hypoxia (5% O2).  Mean +SE, n=8 wells all 911 
experiments. 912 
 913 
Figure 4.  Effects of 10 µM BSO plus 100 µM DEM and either 3 or 10 µM auranofin on 914 
intracellular AzMC and SSP4 fluorescence in HEK293 cells.  BSO, DEM and auranofin were 915 
added to all wells at day 1 and AzMC added to separate wells at days 1, 2 and 3 and SSP4 added 916 
at day 1, 2, 3 and 4.  AzMC fluorescence was inhibited throughout the experimental period, 917 
whereas SSP4 fluorescence was inhibited at day 1 but by day 2-3 this was reversed and there was 918 
more fluorescence in the inhibited cells. Mean +SE, n=8 wells all experiments. 919 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 920 
Figure 5.  Conoidin A concentration-dependently decreases intracellular AzMC fluorescence 921 
and increases SSP4 fluorescence in both normoxic and hypoxic HEK293 cells.  Mean +SE, n=8 922 
wells all experiments. 923 
 924 
Figure 6.  Tiopronin concentration-dependently increases intracellular AzMC fluorescence in 925 
normoxic HEK293 cells and this was further increased in hypoxic cells.  After 21 h AzMC 926 
fluorescence progressively declined in hypoxic cells but continued to rise, albeit slightly in 927 
normoxic cells.  SSP4 fluorescence was decreased by tiopronin in both environments with the 928 
most notable response in hypoxic cells treated with 1 mM.  Mean +SE, n=8 wells all 929 
experiments. 930 
 931 
Figure 7.  Ebselen concentration-dependently decreases intracellular AzMC fluorescence in 932 
normoxic and hypoxic HEK293 cells but has minimal effects on SSP4 fluorescence with the 933 
exception of a delayed increase in fluorescence.  Mean +SE, n=8 wells all experiments. 934 
 935 
Figure 8.  2-AAPA concentration- and time-dependently decreases intracellular AzMC 936 
fluorescence but profoundly, and immediately, increases SSP4 fluorescence in both normoxic 937 
and hypoxic HEK293 cells.  Mean +SE, n=8 wells all experiments. 938 
 939 
Figure 9.  Aminoadipic acid does not affect AzMC or SSP4 fluorescence in either normoxic or 940 
hypoxic HEK293 cells.  Mean +SE, n=8 wells all experiments. 941 
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Figure 10.  Short-term effects of BSO, DEM, tiopronin and conoidin A on AzMC fluorescence 942 
in HEK293 cells.  Mean +SE, n=8 wells all experiments. 943 
Figure 11.  Short-term effects of conoidin A and auranofin on SSP4 fluorescence in HEK293 944 
cells.  Mean +SE, n=8 wells all experiments. 945 
 946 
Figure 12. Effects of BSO plus DEM (10 and 100 µM, respectively), conoidin A (10 µM) and 947 
tiopronin (1 mM) on AzMC (A) and SSP4 (C) fluorescence at 0 and 44 hr and on PrestoBlue 948 
fluorescence in AzMC (B) and SSP4 (D) treated cells 1 h and 2 h after addition of PrestoBlue 949 
(hours 47 and 48 after start of experiment).  (E) PrestoBlue fluorescence after 1 and 2 h in 950 
phosphate buffered saline (PBS).  Mean +SE, n=8 wells all experiments; *, significantly 951 
(p<0.005) different from respective control; #, PrestoBlue fluorescence of SSP4-treated cells 952 
significantly (p<0.005) different from PrestoBlue in PBS; PrestoBlue fluorescence of all AzMC-953 
treated cells was significantly (p<0.05) different from PBS.S 954 
955 
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Supplementary Figures 977 
Figures S1-S10.  (A, D) direct effects of inhibitors on AzMC and SSP4 fluorescence before 978 
addition of inhibitors (t = 0 min) and at 10 and 90 min afterward.  (B, E) effects of inhibitors on 979 
AzMC and SSP4 in the presence of 100 µM (B) or 300 µM (E) H2S.  H2S and inhibitors were 980 
added after t = 0 min.  (C, F) effects of inhibitors on fluorescence of AzMC and SSP4 981 
preactivated for 120 min with 30 µM H2S or 30 µM K2S2, respectively.  Mean +SE, n=4 wells; *, 982 
p<0.05 compared to AzMC or SSP4 only at same time. 983 
 984 
Figure S11.  Effects of AzMC, SSP4, Na2S and K2Sn on PrestoBlue (PB) fluorescence in 985 
phosphate buffered saline.  (A) BP only, (B) plus 25 µM AzMC, (C) plus 300 µM H2S as Na2S, 986 
(D) one hr after 300 µM H2S reaction with 25 µM AzMC, (E) plus 10 µM SSP4, (F) plus 300 987 
µM polysulfide as K2Sn, (G) one hr after 300 µM K2Sn reaction with 10 µM SSP4.  Mean +SE, 988 
n=4 wells.  Note different y axis scale in F. 989 
 990 
Figure S12.  (A) K2Sn concentration response after 1 h with PrestoBlue; X axis numbers 1, 2, 3, 991 
4, 5, 6 correspond to 1, 3, 10, 30, 100, 300 µM K2Sn, respectively.  (B) Effects of 300 µM each 992 
of cysteine (Cys), cystine (CSSC), dithiothreitol (DTT) and 3-mercaptopyruvate (3MP) on 993 
Prestoblue florescence as a function of time.  Mean +SE, n=4 wells (buffer) or 8 wells. 994 
 995 
Figure S13.  (A) Effects of potential interfering molecules on AzMC fluorescence in buffer 996 
compared to H2S; glutathione (GSH), 3-mercaptopyruvate (3-MP), peroxide (H2O2) and sodium 997 
nitroprusside (NP).  Mean +SE, n=4 wells.  (B) Inhibitors of H2S biosynthesis, AOA+PPG 998 
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decrease AzMC fluorescence in HEK293 cells in normoxia (21% O2) at 48 h and in hypoxia 999 
(5% O2) at both 24 and 48h. Mean +SE, 8 wells; *, p<0.05.   1000 
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Reactive oxygen species (ROS) and reactive sulfide species (RSS) are chemically and
biologically similar.
Evolution of antioxidant pathways is more consistent with RSS metabolism than with ROS
metabolism
Here we show that canonical inhibitors of ROS antioxidant pathways affect RSS in HEK293
cells independent of ROS.
These results indicate that antioxidant pathways are involved in RSS metabolism in cells.
RSS may be the actual effector pathway(s) of ROS antioxidant therapies.
